Monocarboxylate transporter 4 facilitates cell proliferation and migration and is associated with poor prognosis in oral squamous cell carcinoma patients

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Zhu, Jiang ^a,b   Wu, Yu Nong ^b   Zhang, Wei ^b   Zhang, Xiao Min ^b   Ding, Xu ^b   Li, Huai Qi ^b   Geng, Meiyu ^c   Xie, Zuo Quan ^c   Wu, He Ming ^a,b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Jiangsu Province Engineering Research Center of Stomatological Translational Medicine   (China)

^c SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA4 INTEGRIN; FOCAL ADHESION KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MONOCARBOXYLATE TRANSPORTER 4; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; SMALL INTERFERING RNA;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER PATIENT; CANCER PROGNOSIS; CELL MIGRATION; CELL PROLIFERATION; DISTANT METASTASIS; DOWN REGULATION; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOLECULAR MECHANICS; MOUTH SQUAMOUS CELL CARCINOMA; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR CLASSIFICATION; TUMOR INVASION; TUMOR RECURRENCE; TUMOR VOLUME;

CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MAP KINASE SIGNALING SYSTEM; MIDDLE AGED; MONOCARBOXYLIC ACID TRANSPORTERS; MOUTH NEOPLASMS; MUSCLE PROTEINS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 84900462660     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087904     Document Type: Article

References (45)

1. Chen YJ, Lin SC, Kao T, Chang CS, Hong PS, et al. (2004) Genome-wide profiling of oral squamous cell carcinoma. J Pathol 204: 326-332. (Pubitemid 39430093)
2. Woolgar JA, Rogers S, West CR, Errington RD, Brown JS, et al. (1999) Survival and patterns of recurrence in 200 oral cancer patients treated by radical surgery and neck dissection. Oral Oncol 35: 257-265. (Pubitemid 29148358)
3. Siegel R, Ward E, Brawley O, Jemal A (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61: 212-236.
4. Walenta S, Salameh A, Lyng H, Evensen JF, Mitze M, et al. (1997) Correlation of high lactate levels in head and neck tumors with incidence of metastasis. Am J Pathol 150: 409-415. (Pubitemid 27073770)
5. Brizel DM, Schroeder T, Scher RL, Walenta S, Clough RW, et al. (2001) Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. Int J Radiat Oncol Biol Phys 51: 349-353. (Pubitemid 32884281)
6. Tripathi P, Kamarajan P, Somashekar BS, MacKinnon N, Chinnaiyan AM, et al. (2012) Delineating metabolic signatures of head and neck squamous cell carcinoma: phospholipase A2, a potential therapeutic target. Int J Biochem Cell Biol 44: 1852-1861.
7. de Souza AC, Justo GZ, de Araujo DR, Cavagis AD (2011) Defining the molecular basis of tumor metabolism: a continuing challenge since Warburg's discovery. Cell Physiol Biochem 28: 771-792.
8. Pinheiro C, Longatto-Filho A, Azevedo-Silva J, Casal M, Schmitt FC, et al. (2012) Role of monocarboxylate transporters in human cancers: state of the art. J Bioenerg Biomembr 44: 127-139.
9. Izumi H, Takahashi M, Uramoto H, Nakayama Y, Oyama T, et al. (2011) Monocarboxylate transporters 1 and 4 are involved in the invasion activity of human lung cancer cells. Cancer Sci 102: 1007-1013.
10. Dimmer KS, Friedrich B, Lang F, Deitmer JW, Broer S (2000) The low-affinity monocarboxylate transporter MCT4 is adapted to the export of lactate in highly glycolytic cells. Biochem J 350 Pt 1: 219-227.
11. Walenta S, Schroeder T, Mueller-Klieser W (2002) Metabolic mapping with bioluminescence: basic and clinical relevance. Biomol Eng 18: 249-262. (Pubitemid 34158559)
12. Stern R, Shuster S, Neudecker BA, Formby B (2002) Lactate stimulates fibroblast expression of hyaluronan and CD44: the Warburg effect revisited. Exp Cell Res 276: 24-31. (Pubitemid 34948348)
13. Rudrabhatla SR, Mahaffey CL, Mummert ME (2006) Tumor microenvironment modulates hyaluronan expression: the lactate effect. J Invest Dermatol 126: 1378-1387. (Pubitemid 43997922)
14. Sonveaux P, Vegran F, Schroeder T, Wergin MC, Verrax J, et al. (2008) Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest 118: 3930-3942.
15. Juel C (1997) Lactate-proton cotransport in skeletal muscle. Physiol Rev 77: 321-358.
16. Pellerin L, Pellegri G, Bittar PG, Charnay Y, Bouras C, et al. (1998) Evidence supporting the existence of an activity-dependent astrocyte-neuron lactate shuttle. Dev Neurosci 20: 291-299. (Pubitemid 28495523)
17. Gallagher SM, Castorino JJ, Wang D, Philp NJ (2007) Monocarboxylate transporter 4 regulates maturation and trafficking of CD147 to the plasma membrane in the metastatic breast cancer cell line MDA-MB-231. Cancer Res 67: 4182-4189. (Pubitemid 46815064)
18. Nakayama Y, Torigoe T, Inoue Y, Minagawa N, Izumi H, et al. (2012) Prognostic significance of monocarboxylate transporter 4 expression in patients with colorectal cancer. Exp Ther Med 3: 25-30.
19. Pertega-Gomes N, Vizcaino JR, Miranda-Goncalves V, Pinheiro C, Silva J, et al. (2011) Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer. BMC Cancer 11: 312.
20. Gerlinger M, Santos CR, Spencer-Dene B, Martinez P, Endesfelder D, et al. (2012) Genome-wide RNA interference analysis of renal carcinoma survival regulators identifies MCT4 as a Warburg effect metabolic target. J Pathol 227: 146-156.
21. Cardinali M, Pietraszkiewicz H, Ensley JF, Robbins KC (1995) Tyrosine phosphorylation as a marker for aberrantly regulated growth-promoting pathways in cell lines derived from head and neck malignancies. Int J Cancer 61: 98-103.
22. Kim HE, Krug MA, Han I, Ensley J, Yoo GH, et al. (2000) Neutron radiation enhances cisplatin cytotoxicity independently of apoptosis in human head and neck carcinoma cells. Clin Cancer Res 6: 4142-4147.
23. Patel V, Ramesh A, Traicoff JL, Baibakov G, Emmert-Buck MR, et al. (2005) Profiling EGFR activity in head and neck squamous cell carcinoma by using a novel layered membrane Western blot technology. Oral Oncol 41: 503-508. (Pubitemid 40692851)
24. Avizienyte E, Wyke AW, Jones RJ, McLean GW, Westhoff MA, et al. (2002) Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signalling. Nat Cell Biol 4: 632-638.
25. Thiery JP (2002) Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454.
26. Dimmer KS, Friedrich B, Lang F, Deitmer JW, Broer S (2000) The low-affinity monocarboxylate transporter MCT4 is adapted to the export of lactate in highly glycolytic cells. Biochem J 350 Pt 1: 219-227.
27. Gatenby RA, Gillies RJ (2004) Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4: 891-899. (Pubitemid 39472955)
28. Gillies RJ, Gatenby RA (2007) Adaptive landscapes and emergent phenotypes: why do cancers have high glycolysis? J Bioenerg Biomembr 39: 251-257. (Pubitemid 47619378)
29. Smallbone K, Gatenby RA, Gillies RJ, Maini PK, Gavaghan DJ (2007) Metabolic changes during carcinogenesis: potential impact on invasiveness. J Theor Biol 244: 703-713. (Pubitemid 46148971)
30. Gallagher SM, Castorino JJ, Philp NJ (2009) Interaction of monocarboxylate transporter 4 with beta1-integrin and its role in cell migration. Am J Physiol Cell Physiol 296: C414-C421.
31. Feron O (2009) Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells. Radiother Oncol 92: 329-333.
32. Hynes RO (1992) Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69: 11-25.
33. Bianchi-Smiraglia A, Paesante S, Bakin AV (2013) Integrin beta5 contributes to the tumorigenic potential of breast cancer cells through the Src-FAK and MEK-ERK signaling pathways. Oncogene 32: 3049-3058.
34. Desgrosellier JS, Cheresh DA (2010) Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer 10: 9-22.
35. Bianchi A, Gervasi ME, Bakin A (2010) Role of beta5-integrin in epithelial-mesenchymal transition in response to TGF-beta. Cell Cycle 9: 1647-1659.
36. Paoli P, Giannoni E, Chiarugi P (2013) Anoikis molecular pathways and its role in cancer progression. Biochim Biophys Acta.
37. McLean GW, Carragher NO, Avizienyte E, Evans J, Brunton VG, et al. (2005) The role of focal-adhesion kinase in cancer - a new therapeutic opportunity. Nat Rev Cancer 5: 505-515. (Pubitemid 40942827)
38. Brunton VG, Avizienyte E, Fincham VJ, Serrels B, Metcalf CR, et al. (2005) Identification of Src-specific phosphorylation site on focal adhesion kinase: dissection of the role of Src SH2 and catalytic functions and their consequences for tumor cell behavior. Cancer Res 65: 1335-1342. (Pubitemid 40270160)
39. Sieg DJ, Hauck CR, Ilic D, Klingbeil CK, Schaefer E, et al. (2000) FAK integrates growth-factor and integrin signals to promote cell migration. Nat Cell Biol 2: 249-256.
40. Lin TH, Aplin AE, Shen Y, Chen Q, Schaller M, et al. (1997) Integrin-mediated activation of MAP kinase is independent of FAK: evidence for dual integrin signaling pathways in fibroblasts. J Cell Biol 136: 1385-1395. (Pubitemid 27421923)
41. Schlaepfer DD, Jones KC, Hunter T (1998) Multiple Grb2-mediated integrin-stimulated signaling pathways to ERK2/mitogen-activated protein kinase: summation of both c-Src- and focal adhesion kinase-initiated tyrosine phosphorylation events. Mol Cell Biol 18: 2571-2585. (Pubitemid 28183427)
42. Schlaepfer DD, Hanks SK, Hunter T, van der Geer P (1994) Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature 372: 786-791.
43. Frisch SM, Screaton RA (2001) Anoikis mechanisms. Curr Opin Cell Biol 13: 555-562. (Pubitemid 32817013)
44. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, et al. (1991) E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113: 173-185. (Pubitemid 21909684)
45. Hirohashi S (1998) Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 153: 333-339.